Anna Cappelletti
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
-
- Blood disorders and treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- SARS-CoV-2 detection and testing 3
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS Research and Interventions 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Stefan Lethagen (3 shared papers)Giancarlo Castaman (3 shared papers)Francesco Rodeghiero (3 shared papers)Jeroen Eikenboom (3 shared papers)Alberto Tosetto (3 shared papers)Alok Srivastava (2 shared papers)Silvia Linari (2 shared papers)F. Baudo (2 shared papers)
- Journals
- Diagnosis (2 papers)Journal of Thrombosis and Haemostasis (2 papers)Clinical Infectious Diseases (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Clinica Chimica Acta (1 paper)
- Partner nations
- ItalyNetherlandsSweden
In The Last Decade
Anna Cappelletti
14 papers receiving 483 citations
Peers
Comparison fields: 5 of 66
- Hematology 296
- Genetics 70
- Virology 27
- Internal Medicine 20
- Cardiology and Cardiovascular Medicine 89
Countries citing papers authored by Anna Cappelletti
This map shows the geographic impact of Anna Cappelletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Cappelletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Cappelletti more than expected).
Fields of papers citing papers by Anna Cappelletti
This network shows the impact of papers produced by Anna Cappelletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Cappelletti. The network helps show where Anna Cappelletti may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Cappelletti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 237 | |
| 2 | 2002 | 55 | |
| 3 | 2006 | 46 | |
| 4 | 2000 | 42 | |
| 5 | 2004 | 32 | |
| 6 | 2010 | 22 | |
| 7 | 2011 | 20 | |
| 8 | 2003 | 12 | |
| 9 | 2021 | 8 | |
| 10 | 2008 | 8 | |
| 11 | 2020 | 5 | |
| 12 | 2005 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2025 | 0 |
About Anna Cappelletti
Anna Cappelletti is a scholar working on Infectious Diseases, Epidemiology, Hematology, Emergency Medicine and Surgery, having authored 15 papers that have together received 492 indexed citations. Recurring topics across this work include SARS-CoV-2 detection and testing (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HIV-related health complications and treatments (3 papers), Platelet Disorders and Treatments (3 papers), HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), COVID-19 Clinical Research Studies (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Hematology (296 citations), Genetics (70 citations), Virology (27 citations), Internal Medicine (20 citations) and Cardiology and Cardiovascular Medicine (89 citations). Anna Cappelletti has collaborated with scholars based in Italy, Netherlands and Sweden. Frequent co-authors include Stefan Lethagen, Giancarlo Castaman, Francesco Rodeghiero, Jeroen Eikenboom, Alberto Tosetto, Alok Srivastava, Silvia Linari, F. Baudo, Javier Batlle and A B Federici. Their work appears in journals such as Diagnosis, Journal of Thrombosis and Haemostasis, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.